Characteristics of the patients
| Covariates . | No. . |
|---|---|
| Recipient gender | |
| Male | 36 |
| Female | 33 |
| Recipient cytomegalovirus serology | |
| Negative | 41 |
| Positive | 24 |
| Malformative syndrome | |
| Limited (<3 sites) | 44 |
| Extensive (≥3 sites) | 23 |
| Androgen therapy before transplant | |
| No | 27 |
| Yes | 41 |
| Elevated transaminases before conditioning | |
| No | 51 |
| Yes | 15 |
| Number of pretransplant transfusions | |
| <20 | 23 |
| ≥20 | 43 |
| Hemogram at transplant | |
| Hemoglobin level | |
| <80 g/L | 20 |
| ≥80 g/L | 45 |
| Absolute neutrophil count | |
| <0.5 109/L | 19 |
| ≥0.5 109/L | 47 |
| Platelet count | |
| <20 109/L | 14 |
| ≥20 109/L | 50 |
| Covariates . | No. . |
|---|---|
| Recipient gender | |
| Male | 36 |
| Female | 33 |
| Recipient cytomegalovirus serology | |
| Negative | 41 |
| Positive | 24 |
| Malformative syndrome | |
| Limited (<3 sites) | 44 |
| Extensive (≥3 sites) | 23 |
| Androgen therapy before transplant | |
| No | 27 |
| Yes | 41 |
| Elevated transaminases before conditioning | |
| No | 51 |
| Yes | 15 |
| Number of pretransplant transfusions | |
| <20 | 23 |
| ≥20 | 43 |
| Hemogram at transplant | |
| Hemoglobin level | |
| <80 g/L | 20 |
| ≥80 g/L | 45 |
| Absolute neutrophil count | |
| <0.5 109/L | 19 |
| ≥0.5 109/L | 47 |
| Platelet count | |
| <20 109/L | 14 |
| ≥20 109/L | 50 |